It could be that mutations effecting FOXF1 or FENDRR could reduce ACTA2 activity resulting in cellular dysfunction akin to that seen in Multisystemic Smooth Muscle Dysfunction Syndrome. The gene discussed is ACTA2; the disease is multisystemic smooth muscle dysfunction syndrome.